Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Sanofi discloses phenoxypropanolamines as beta3-adrenoceptor antagonists

April 16, 1998

New agent for prevention of HCV in development at Nabi

April 15, 1998

Antiviral drugs advisory committee will discuss Intron A/Rebetol NDA

April 15, 1998

Adefovir dipivoxil shows promise in the treatment of hepatitis B

April 14, 1998

H. pylori infection and the pathogenesis of gastric disorders

April 14, 1998

Schering-Plough and Centocor announce international licensing agreement for Avakine

April 8, 1998

Ro-25-3036 improves dosing frequency of IFN in hepatitis patients

April 8, 1998

Novel antisecretory/antiulcer agent from Shionogi undergoes evaluation in Japan

April 7, 1998

YM-905 shows promising activity in animal model of IBS

April 6, 1998

Eisai files NDA for Aciphex, novel treatment for GERD and ulcers

April 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...